3 Firms Guide Biotech's $110M PIPE, Buy Of PE-Backed Co.
Rare disease-focused Catabasis Pharmaceuticals said Friday it landed roughly $110 million in a private investment in public equity, or PIPE, deal led by life sciences investor Perceptive Advisors after buying a...To view the full article, register now.
Already a subscriber? Click here to view full article